McDonald's Corporation · MCD · FY2026 Q3 · Calendar Q4 2026
McDonald’s Q3: Value Initiatives Lift U.S. Trend, Execution Risks Persist
Q3 analysis points to early improvement in U.S. comparable sales following value and digital initiatives, alongside continued international growth. The durability of that progress depends on effective value execution and franchisee alignment in a soft consumer environment.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about MCD FY2026 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter’s reported U.S. execution and value-menu gaps, management’s Q3 analysis describes U.S. comparable sales turning positive in September after value-focused and digital interventions. The discussion now centers on a planned national entry-level value program and continued specialty-beverage and restaurant-transformation efforts.
Guidance delta
Guidance sentiment remained maintained. The supplied analysis says 2026 capex is projected at $3.7 billion, at the low end of prior guidance; it also describes an early-2027 national value-program rollout.
Key takeaways
- Management’s analysis reports 1.5% global comparable-sales growth in Q3 and a return to positive U.S. comparable sales in September.
- Value offers and digital initiatives are central to the described U.S. improvement; a national entry-level value program is planned for early 2027.
- International growth and specialty beverages remain priorities, while management also highlighted remodels and smart-ordering initiatives.
- The supplied analysis identifies consumer softness, regional disruptions and execution as material offsets.
Management priorities
- Improve value positioning and maintain franchisee alignment on the planned value program.
- Expand specialty beverages and digital offers.
- Advance restaurant remodels and smart-ordering initiatives.
Follow MCD with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 4, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Mizuho | Neutral | Neutral | Maintain | Oct 30, 2026 |
| BTIG | Buy | Buy | Maintain | Oct 26, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 20, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Oct 8, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Oct 6, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 5, 2026 |
| Guggenheim | Neutral | Neutral | Maintain | Oct 5, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Sep 29, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Sep 28, 2026 |
| Melius Research | Sell | Sell | Maintain | Sep 28, 2026 |
| TD Cowen | Hold | Hold | Maintain | Sep 24, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Sep 24, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Sep 24, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Sep 24, 2026 |
| UBS | Buy | Buy | Maintain | Sep 21, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Sep 14, 2026 |
| Argus Research | Buy | Buy | Maintain | Aug 26, 2026 |
| Tigress Financial | Buy | Buy | Maintain | Jul 17, 2026 |
| Barclays | Overweight | Overweight | Maintain | May 8, 2026 |
| Rothschild & Co | Neutral | Sell | Upgrade | Apr 23, 2026 |
| Truist Securities | Buy | Buy | Maintain | Feb 12, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Feb 12, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 12, 2026 |
| Oppenheimer | Outperform | Perform | Upgrade | Jan 6, 2026 |
| Baird | Neutral | Neutral | Maintain | Nov 6, 2025 |
| Stifel | Hold | Hold | Maintain | Aug 22, 2025 |
| B of A Securities | Neutral | Neutral | Maintain | Jul 18, 2025 |
| Goldman Sachs | Buy | Neutral | Upgrade | Jul 10, 2025 |
| Redburn Atlantic | Sell | Buy | Downgrade | Jun 10, 2025 |
| Loop Capital | Hold | Buy | Downgrade | Jun 6, 2025 |
| TD Securities | Hold | Hold | Maintain | Jun 5, 2025 |
| Wedbush | Outperform | Outperform | Maintain | Feb 11, 2025 |
| Erste Group | Hold | Buy | Downgrade | Apr 3, 2024 |
| Stephens & Co. | Overweight | Overweight | Maintain | Feb 6, 2024 |
| DZ Bank | Buy | Hold | Upgrade | Oct 31, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Apr 26, 2023 |
| Northcoast Research | Buy | Neutral | Upgrade | Apr 10, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Oct 28, 2022 |
| Kalinowski Research | Buy | Neutral | Upgrade | Aug 15, 2022 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Jun 29, 2022 |
| MKM Partners | Buy | Buy | Maintain | Apr 29, 2022 |
| Telsey Advisory Group | Outperform | Outperform | Maintain | May 4, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 1, 2020 |
| Kalinowski | Buy | Neutral | Upgrade | Jan 22, 2020 |
| Longbow Research | Buy | Neutral | Upgrade | Nov 8, 2019 |
| Piper Jaffray | Neutral | Overweight | Downgrade | Nov 4, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Jul 29, 2019 |
| Bank of America | Buy | Buy | Maintain | Jun 7, 2019 |
| Gordon Haskett | Buy | Buy | Maintain | Oct 19, 2018 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| Nomura | Buy | Buy | Maintain | Feb 1, 2018 |
| Canaccord Genuity | Hold | Hold | Maintain | Aug 22, 2016 |
| BTIG Research | Buy | Buy | Maintain | Apr 25, 2016 |
| PiperJaffray | Overweight | Neutral | Upgrade | Oct 23, 2015 |
| Cleveland Research | Neutral | Neutral | Maintain | Jul 8, 2015 |
| Susquehanna | Neutral | Positive | Downgrade | Jul 23, 2014 |
| Sterne Agee | Neutral | Buy | Downgrade | Jul 23, 2014 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Jul 17, 2013 |
| Janney Capital | Neutral | Buy | Downgrade | Jul 17, 2013 |
| Credit Agricole | Outperform | Buy | Maintain | Apr 22, 2013 |
| Raymond James | Market Perform | Outperform | Downgrade | Jan 9, 2013 |
| Lazard | Neutral | Buy | Downgrade | Nov 26, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $279.06. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Bernstein | Analyst unavailable | $250 | $230.88 | -10.4% | Oct 8, 2026 |
| KeyBanc | Analyst unavailable | $280 | $233.04 | +0.3% | Oct 6, 2026 |
| Guggenheim | Gregory Francfort | $250 | $231.89 | -10.4% | Oct 5, 2026 |
| Wells Fargo | Zachary Fadem | $270 | $231.89 | -3.2% | Oct 5, 2026 |
| Morgan Stanley | Brian Harbour | $297 | $236.5 | +6.4% | Sep 28, 2026 |
| Melius Research | Jacob Aiken-Phillips | $230 | $236.5 | -17.6% | Sep 28, 2026 |
| H.C. Wainwright | Analyst unavailable | $250 | $237.02 | -10.4% | Sep 25, 2026 |
| Robert W. Baird | Chris O'Cull | $250 | $238.31 | -10.4% | Sep 24, 2026 |
| Oppenheimer | Analyst unavailable | $295 | $240.37 | +5.7% | Sep 24, 2026 |
| RBC Capital | Logan Reich | $285 | $241.42 | +2.1% | Sep 24, 2026 |
| Jefferies | Andy Barish | $325 | $238.32 | +16.5% | Sep 24, 2026 |
| UBS | Analyst unavailable | $260 | $238.32 | -6.8% | Sep 24, 2026 |
| BMO Capital | Andrew Strelzik | $310 | $238.32 | +11.1% | Sep 24, 2026 |
| Cowen & Co. | Analyst unavailable | $270 | $238.32 | -3.2% | Sep 24, 2026 |
| UBS | Analyst unavailable | $320 | $248.24 | +14.7% | Sep 21, 2026 |
| RBC Capital | Analyst unavailable | $290 | $257.49 | +3.9% | Sep 15, 2026 |
| Deutsche Bank | Lauren Silberman | $300 | $257.78 | +7.5% | Sep 14, 2026 |
| Morgan Stanley | Analyst unavailable | $308 | $252.53 | +10.4% | Sep 14, 2026 |
| Argus Research | Analyst unavailable | $310 | $267.07 | +11.1% | Aug 26, 2026 |
| Guggenheim | Analyst unavailable | $290 | $273.21 | +3.9% | Aug 5, 2026 |
| Bernstein | Danilo Gargiulo | $295 | $273.92 | +5.7% | Aug 5, 2026 |
| UBS | Analyst unavailable | $305 | $273.35 | +9.3% | Aug 5, 2026 |
| Morgan Stanley | Analyst unavailable | $319 | $273.25 | +14.3% | Aug 5, 2026 |
| Robert W. Baird | Analyst unavailable | $285 | $268.34 | +2.1% | Aug 5, 2026 |
| Deutsche Bank | Lauren Silberman | $345 | $268.34 | +23.6% | Aug 5, 2026 |
| Piper Sandler | Analyst unavailable | $286 | $267.34 | +2.5% | Aug 4, 2026 |
| UBS | Dennis Geiger | $340 | $267.14 | +21.8% | Jul 27, 2026 |
| BTIG | Analyst unavailable | $350 | $262.8 | +25.4% | Jul 24, 2026 |
| Evercore ISI | Analyst unavailable | $320 | $262.58 | +14.7% | Jul 23, 2026 |
| Wells Fargo | Analyst unavailable | $300 | $264.95 | +7.5% | Jul 16, 2026 |
| Morgan Stanley | Analyst unavailable | $322 | $268.94 | +15.4% | Jul 15, 2026 |
| Deutsche Bank | Analyst unavailable | $325 | $273.98 | +16.5% | Jul 9, 2026 |
| KeyBanc | Analyst unavailable | $315 | $269.76 | +12.9% | Jun 29, 2026 |
| Morgan Stanley | Analyst unavailable | $331 | $281.05 | +18.6% | May 8, 2026 |
| Evercore ISI | Analyst unavailable | $350 | $279.42 | +25.4% | May 8, 2026 |
| Wells Fargo | Analyst unavailable | $320 | $283.7 | +14.7% | May 8, 2026 |
| Robert W. Baird | Analyst unavailable | $305 | $283.7 | +9.3% | May 7, 2026 |
| Redburn Partners | Analyst unavailable | $306 | $300.07 | +9.7% | Apr 23, 2026 |
| KeyBanc | Analyst unavailable | $345 | $311.36 | +23.6% | Apr 20, 2026 |
| Tigress Financial | Ivan Feinseth | $385 | $325.44 | +38.0% | Mar 6, 2026 |
| Argus Research | John Staszak | $380 | $332.08 | +36.2% | Feb 13, 2026 |
| Guggenheim | Analyst unavailable | $320 | $332.08 | +14.7% | Feb 13, 2026 |
| Truist Financial | Jake Bartlett | $370 | $330.19 | +32.6% | Feb 12, 2026 |
| RBC Capital | Logan Reich | $330 | $330.56 | +18.3% | Feb 12, 2026 |
| Jefferies | Analyst unavailable | $375 | $323.88 | +34.4% | Feb 12, 2026 |
| Barclays | Analyst unavailable | $380 | $330.2 | +36.2% | Feb 12, 2026 |
| Robert W. Baird | David Tarantino | $335 | $323.21 | +20.0% | Feb 12, 2026 |
| UBS | Analyst unavailable | $365 | $323.21 | +30.8% | Feb 12, 2026 |
| Bernstein | Danilo Gargiulo | $340 | $323.21 | +21.8% | Feb 12, 2026 |
| BTIG | Analyst unavailable | $370 | $323.21 | +32.6% | Feb 12, 2026 |
| Wells Fargo | Analyst unavailable | $355 | $323.21 | +27.2% | Feb 12, 2026 |
| Mizuho Securities | Analyst unavailable | $325 | $323.48 | +16.5% | Feb 6, 2026 |
| Guggenheim | Gregory Francfort | $325 | $318.53 | +16.5% | Feb 3, 2026 |
| UBS | Dennis Geiger | $350 | $318.17 | +25.4% | Feb 2, 2026 |
| BTIG | Analyst unavailable | $360 | $315 | +29.0% | Feb 2, 2026 |
| Truist Financial | Jake Bartlett | $356 | $304.16 | +27.6% | Jan 8, 2026 |
| Bernstein | Jeffrey Bernstein | $372 | $302.77 | +33.3% | Jan 7, 2026 |
| Oppenheimer | Brian Bittner | $355 | $302.77 | +27.2% | Jan 6, 2026 |
| Mizuho Securities | Analyst unavailable | $300 | $310 | +7.5% | Oct 27, 2025 |
| Piper Sandler | Brian Mullan | $325 | $312.3 | +16.5% | Oct 22, 2025 |
| Barclays | Analyst unavailable | $362 | $307.48 | +29.7% | Oct 22, 2025 |
| KeyBanc | Eric Gonzalez | $335 | $308.09 | +20.0% | Oct 20, 2025 |
| Morgan Stanley | Brian Harbour | $335 | $307.07 | +20.0% | Oct 17, 2025 |
| Wells Fargo | Analyst unavailable | $340 | $305.25 | +21.8% | Oct 16, 2025 |
| Guggenheim | Analyst unavailable | $295 | $293.81 | +5.7% | Oct 10, 2025 |
| RBC Capital | Analyst unavailable | $320 | $294.4 | +14.7% | Oct 8, 2025 |
| Stifel Nicolaus | Chris O'Cull | $315 | $314.07 | +12.9% | Aug 22, 2025 |
| BMO Capital | Andrew Strelzik | $345 | $315.72 | +23.6% | May 5, 2025 |
| Truist Financial | Jake Bartlett | $350 | $311.96 | +25.4% | May 2, 2025 |
| KeyBanc | Eric Gonzalez | $340 | $312.69 | +21.8% | Mar 27, 2025 |
| BMO Capital | Andrew Strelzik | $335 | $291.52 | +20.0% | Oct 30, 2024 |
| Truist Financial | Jake Bartlett | $342 | $295 | +22.6% | Oct 29, 2024 |
| Robert W. Baird | David Tarantino | $290 | $296.79 | +3.9% | Oct 29, 2024 |
| Wedbush | Nick Setyan | $295 | $297.62 | +5.7% | Oct 23, 2024 |
| Goldman Sachs | Christine Cho | $325 | $314.69 | +16.5% | Oct 23, 2024 |
| Guggenheim | Gregory Francfort | $285 | $314.69 | +2.1% | Oct 23, 2024 |
| Evercore ISI | David Palmer | $340 | $314.69 | +21.8% | Oct 23, 2024 |
| Bank of America Securities | Sara Senatore | $322 | $316.56 | +15.4% | Oct 21, 2024 |
| Morgan Stanley | Brian Harbour | $340 | $313.34 | +21.8% | Oct 15, 2024 |
| UBS | Dennis Geiger | $345 | $301.9 | +23.6% | Oct 9, 2024 |
| KeyBanc | Eric Gonzalez | $330 | $303.76 | +18.3% | Oct 7, 2024 |
| Citigroup | Jon Tower | $317 | $302.98 | +13.6% | Oct 2, 2024 |
| Citigroup | Jon Tower | $301 | $292.35 | +7.9% | Sep 13, 2024 |
| Bank of America Securities | Sara Senatore | $278 | $264.8 | -0.4% | Jul 30, 2024 |
| Bernstein | Jeffrey Bernstein | $300 | $263.49 | +7.5% | Jul 30, 2024 |
| Loop Capital Markets | Alton Stump | $342 | $266.44 | +22.6% | Jul 30, 2024 |
| BMO Capital | Andrew Strelzik | $315 | $266.44 | +12.9% | Jul 30, 2024 |
| Citigroup | Jon Tower | $275 | $261.42 | -1.5% | Jul 30, 2024 |
| KeyBanc | Eric Gonzalez | $305 | $261.42 | +9.3% | Jul 30, 2024 |
| Wells Fargo | Jon Tower | $285 | $261.42 | +2.1% | Jul 30, 2024 |
| Jefferies | Andy Barish | $310 | $262.56 | +11.1% | Jul 29, 2024 |
| Truist Financial | Jake Bartlett | $295 | $261.42 | +5.7% | Jul 29, 2024 |
| Stifel Nicolaus | Chris O'Cull | $257 | $262.1 | -7.9% | Jul 29, 2024 |
| Deutsche Bank | Lauren Silberman | $295 | $252 | +5.7% | Jul 29, 2024 |
| Stifel Nicolaus | Chris O'Cull | $265 | $257.28 | -5.0% | Jul 22, 2024 |
| Guggenheim | Gregory Francfort | $280 | $249.99 | +0.3% | Jul 2, 2024 |
| Maxim Group | Thomas Forte | $222.5 | $126.18 | -20.3% | Jun 13, 2024 |
| Goldman Sachs | Christine Cho | $288 | $254.48 | +3.2% | Jun 13, 2024 |
| Loop Capital Markets | Eric Gonzalez | $310 | $252.07 | +11.1% | May 31, 2024 |
| Truist Financial | Jake Bartlett | $320 | $274.43 | +14.7% | May 2, 2024 |
| BMO Capital | Andrew Strelzik | $330 | $272.07 | +18.3% | May 1, 2024 |
| Stifel Nicolaus | Chris O'Cull | $285 | $273.04 | +2.1% | Apr 30, 2024 |
| Morgan Stanley | Brian Harbour | $320 | $266.8 | +14.7% | Apr 12, 2024 |
| Stifel Nicolaus | Chris O'Cull | $300 | $268.67 | +7.5% | Apr 11, 2024 |
| Piper Sandler | Aisling Grueninger | $299 | $267.56 | +7.1% | Apr 9, 2024 |
| UBS | Dennis Geiger | $335 | $270.09 | +20.0% | Apr 5, 2024 |
| Truist Financial | Jake Bartlett | $340 | $283.46 | +21.8% | Feb 6, 2024 |
| Stephens | Joshua Long | $320 | $285.94 | +14.7% | Feb 5, 2024 |
| RBC Capital | Christopher Carril | $315 | $262.17 | +12.9% | Oct 31, 2023 |
| Stephens | Joshua Long | $325 | $294.03 | +16.5% | Jul 28, 2023 |
| Oppenheimer | Brian Bittner | $315 | $288.55 | +12.9% | Apr 13, 2023 |
| RBC Capital | Analyst unavailable | $283 | $263.74 | +1.4% | Feb 3, 2023 |
| Credit Suisse | Analyst unavailable | $300 | $267.23 | +7.5% | Feb 1, 2023 |
| Truist Financial | Analyst unavailable | $292 | $267.4 | +4.6% | Feb 1, 2023 |
| Citigroup | Jon Tower | $266.29 | $267.4 | -4.6% | Feb 1, 2023 |
| Citigroup | Analyst unavailable | $277 | $267.4 | -0.7% | Feb 1, 2023 |
| Barclays | Analyst unavailable | $310 | $264.39 | +11.1% | Jan 5, 2023 |
| Jefferies | Analyst unavailable | $315 | $267.25 | +12.9% | Dec 21, 2022 |
| Citigroup | Analyst unavailable | $246 | $243.76 | -11.8% | Sep 27, 2022 |
| Bernstein | Analyst unavailable | $267 | $258.42 | -4.3% | Sep 8, 2022 |
| Piper Sandler | Analyst unavailable | $270 | $254.39 | -3.2% | Sep 7, 2022 |
| Tigress Financial | Analyst unavailable | $320 | $255.16 | +14.7% | Aug 30, 2022 |
| BMO Capital | Analyst unavailable | $300 | $266.82 | +7.5% | Aug 18, 2022 |
| Credit Suisse | Analyst unavailable | $287 | $256.43 | +2.8% | Jul 27, 2022 |
| Barclays | Analyst unavailable | $285 | $257.09 | +2.1% | Jul 27, 2022 |
| Citigroup | Analyst unavailable | $275 | $257.09 | -1.5% | Jul 27, 2022 |
| RBC Capital | Analyst unavailable | $305 | $257.09 | +9.3% | Jul 27, 2022 |
| BMO Capital | Analyst unavailable | $285 | $257.09 | +2.1% | Jul 27, 2022 |
| Cowen & Co. | Analyst unavailable | $290 | $257.09 | +3.9% | Jul 27, 2022 |
| Morgan Stanley | Analyst unavailable | $285 | $254.22 | +2.1% | Jul 18, 2022 |
| Deutsche Bank | Analyst unavailable | $263 | $252.5 | -5.8% | Jul 7, 2022 |
| Atlantic Equities | Edward Lewis | $278 | $242.83 | -0.4% | Jun 29, 2022 |
| Barclays | Analyst unavailable | $289 | $245.61 | +3.6% | Jun 9, 2022 |
| Truist Financial | Analyst unavailable | $273 | $242.21 | -2.2% | May 25, 2022 |
| Atlantic Equities | Edward Lewis | $245 | $243.5 | -12.2% | May 16, 2022 |
| J.P. Morgan | Analyst unavailable | $275 | $242.77 | -1.5% | May 3, 2022 |
| MKM Partners | Analyst unavailable | $295 | $252.32 | +5.7% | Apr 29, 2022 |
| RBC Capital | Analyst unavailable | $295 | $254.19 | +5.7% | Apr 29, 2022 |
| Citigroup | Analyst unavailable | $273 | $254.19 | -2.2% | Apr 29, 2022 |
| BTIG | Peter Saleh | $280 | $250.14 | +0.3% | Apr 25, 2022 |
| RBC Capital | Christopher Carril | $287 | $248.16 | +2.8% | Apr 25, 2022 |
| Citigroup | Jon Tower | $270 | $250.51 | -3.2% | Apr 17, 2022 |
| UBS | Dennis Geiger | $290 | $249.25 | +3.9% | Apr 3, 2022 |
| Morgan Stanley | John Glass | $287 | $241.58 | +2.8% | Mar 25, 2022 |
| Oppenheimer | Brian Bittner | $280 | $237.47 | +0.3% | Mar 17, 2022 |
| Stephens | James Rutherford | $280 | $222.79 | +0.3% | Mar 8, 2022 |
| Robert W. Baird | David Tarantino | $283 | $222.79 | +1.4% | Mar 8, 2022 |
| Bernstein | Jeffrey Bernstein | $305 | $260.06 | +9.3% | Feb 6, 2022 |
| Barclays | Jeff Bernstein | $305 | $254.67 | +9.3% | Jan 28, 2022 |
| Wedbush | Nick Setyan | $270 | $254.67 | -3.2% | Jan 28, 2022 |
| Credit Suisse | Lauren Silberman | $285 | $254.67 | +2.1% | Jan 28, 2022 |
| BMO Capital | Andrew Strelzik | $270 | $254.67 | -3.2% | Jan 28, 2022 |
| Evercore ISI | David Palmer | $300 | $254.67 | +7.5% | Jan 28, 2022 |
| Stifel Nicolaus | Chris O`Cull | $260 | $247.36 | -6.8% | Jan 27, 2022 |
| Jefferies | Andy Barish | $306 | $247.36 | +9.7% | Jan 27, 2022 |
| Goldman Sachs | Jared Garber | $284 | $247.36 | +1.8% | Jan 27, 2022 |
| RBC Capital | Christopher Carril | $303 | $247.36 | +8.6% | Jan 27, 2022 |
| Truist Financial | Jake Bartlett | $280 | $247.36 | +0.3% | Jan 27, 2022 |
| BTIG | Peter Saleh | $295 | $247.36 | +5.7% | Jan 27, 2022 |
| KeyBanc | Eric Gonzalez | $285 | $248.47 | +2.1% | Jan 26, 2022 |
| Piper Sandler | Nicole Miller | $282 | $268.58 | +1.1% | Jan 3, 2022 |
| Argus Research | John Staszak | $300 | $265.73 | +7.5% | Dec 30, 2021 |
| Loop Capital Markets | Alton Stump | $306 | $247.95 | +9.7% | Dec 3, 2021 |
| Guggenheim | Gregory Francfort | $275 | $242.8 | -1.5% | Oct 28, 2021 |
| Deutsche Bank | Brian Mullan | $268 | $242.8 | -4.0% | Oct 28, 2021 |
| Wells Fargo | Jon Tower | $276 | $239.98 | -1.1% | Oct 13, 2021 |
| Gordon Haskett Capital Corporation | Jeff Farmer | $260 | $230.43 | -6.8% | Jul 20, 2021 |
Track every rating change on MCD the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationMcDonald's Corporation operates and licenses its renowned fast-food chain worldwide, with a significant presence in both the United States and international markets. Their comprehensive menu offers classic items like hamburgers and cheeseburgers, a variety of chicken options including sandwiches and nuggets, alongside lighter choices such as wraps, french fries, and salads. For breakfast, patrons can select from offerings like biscuit and bagel sandwiches, breakfast burritos, and hotcakes. Additionally, the company provides oatmeal, an assortment of desserts including milkshakes, sundaes, and soft-serve ice cream, plus a selection of baked goods. A wide array of soft drinks, coffee, and other beverages completes their offering. By December 31, 2021, the corporation's global network encompassed 40,031 establishments. McDonald's Corporation, founded in 1940, has its main corporate office located in Chicago, Illinois.
Historical context
All MCD earningsConsumer Cyclical peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| SN SharkNinja, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +6.1% | SharkNinja lifts 2026 outlook after another quarter of 20%+ sales growth |
| CPNG Coupang, Inc. | FY2026 Q3 · Calendar Q4 2026 | -90.3% | +13.3% | Coupang’s growth and membership momentum continue as margins remain pressured |
| BALL Ball Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.8% | -7.1% | Ball reports broad-based can-volume growth, with new capacity and cost risks ahead |
| RACE Ferrari N.V. | FY2026 Q3 · Calendar Q4 2026 | +5.6% | +2.9% | Ferrari raises 2026 guidance as personalization and order-book strength support Q3 |
| YUM Yum! Brands, Inc. | FY2026 Q3 · Calendar Q4 2026 | +3.3% | -0.4% | Yum’s post-divestiture focus meets a Taco Bell recovery test |
Latest beats and misses
Who reports nextBeat on EPS
- WTRGFY2026 Q3 · November 3, 2026+13.7% EPS+2.5% move
- LTMFY2026 Q3 · November 3, 2026+25.2% EPS+9.5% move
- AIZFY2026 Q3 · November 3, 2026+29.5% EPS+4.2% move
- AIZNFY2026 Q3 · November 3, 2026+36.0% EPS+0.5% move
- SMCIFY2027 Q1 · November 3, 2026+47.2% EPS-4.2% move
- XYZFY2026 Q3 · November 3, 2026+9.7% EPS+14.9% move
Missed on EPS
- BSACFY2026 Q3 · October 30, 2026-20.0% EPS-3.0% move
- TXFY2026 Q3 · November 3, 2026-24.9% EPS-0.0% move
- CHTFY2026 Q3 · November 4, 2026-55.7% EPS+0.9% move
- TOSTFY2026 Q3 · November 3, 2026-20.1% EPS+5.9% move
- CPNGFY2026 Q3 · November 3, 2026-90.3% EPS+13.3% move
- TLNFY2026 Q3 · November 3, 2026-65.4% EPS+7.3% move
Get the MCD recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-11-04T17:09:24.794286+00:00
- FN2 earnings calendar · 2026-11-04T01:23:13.345574+00:00
- Polygon adjusted daily market bars · 2026-11-04T17:50:47.647776+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-04T17:50:47.645020+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-04. For educational purposes only; not investment advice.